Not only does this stock offer a yield near 6% and inflation-beating dividend growth, but shares are potentially 12% undervalued at current prices.
This is a high-quality healthcare firm that is positioned extremely favorably in regard to long-term, global demographic trends. These tailwinds are powerful, and the company is poised to continue pumping out growing dividends for many years to come. With the potential that shares are 15% undervalued on top of market-beating income, this is a compelling long-term dividend growth investment idea in the healthcare space.
This is a high-quality firm that’s extremely well positioned to capture plenty of growth from simple and long-term global trends. An incredible track record for growing its profit and dividend looks set to continue for many years to come. Meanwhile, the stock appears 13% undervalued and offers a yield near 3% on a well-funded dividend. Dividend growth investors would do well to strongly consider this stock for long-term investment.